Palvella Therapeutics, Inc.
PVLA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583648
In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Palvella Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +18 vs. Q1 2026
- Shares held
- 14.1M
- +904.8K (+6.9%) vs. Q1 2026
- Total value
- $2.15B
- +$508.7M (+31.1%) vs. Q1 2026
- New holders
- 37
- 88 more added
- Sold out
- 19
- 42 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $2.15B |
| Q1 2026 | 180 | $1.64B |
| Q4 2025 | 140 | $1.02B |
| Q3 2025 | 100 | $534.5M |
| Q2 2025 | 67 | $133.2M |
| Q1 2025 | 41 | $143.4M |
| Q4 2024 | 33 | $48.4M |
| Q3 2024 | 25 | $10.1M |
| Q2 2024 | 20 | $3.57M |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlueCrest Capital Management Ltd | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −18,962−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −8,232−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −7,726−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −6,652−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −5,903−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −2,140−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −1,791−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −1,606−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Swiss Life Asset Management Ltd | 0 | $0 | 0.00% | −471−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |